Substrate mediated enzyme prodrug therapy

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review


Substrate mediated enzyme prodrug therapy (SMEPT) is a biomedical platform developed to perform a localized synthesis of drugs mediated by implantable biomaterials. This approach combines the benefits and at the same time offers to overcome the drawbacks for traditional pill-based drug administration and site-specific, implant mediated drug delivery. Specifically, SMEPT offers the flexibility of delivering multiple drugs - individually as monotherapy, in sequence, or as a combination therapy, all of which is also accomplished in a site-specific manner. This technology is also unique for site-specific synthesis of drugs with short half-life, such as nitric oxide. This review presents historical development of SMEPT from early reports to the most recent examples, and also outlines potential avenues for subsequent development of this platform.

Original languageEnglish
JournalAdvanced Drug Delivery Reviews
Pages (from-to)24-34
Number of pages11
Publication statusPublished - 2017


  • Journal Article
  • Review


Dive into the research topics of 'Substrate mediated enzyme prodrug therapy'. Together they form a unique fingerprint.

Cite this